Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/10/2019
SIETES contiene 92822 citas

 
 
<< anterior 21 a 40 de 347 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Li B-Z, Threapleton DE, Wang JY, Xu J-M, Yuan J-Q, Zhang C, Li P, Ye Q-L, Guo B, Mao C, Ye DQ. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ 2015;351:h4052. [Ref.ID 99413]
22.Tiene citas relacionadas Cita con resumen
Braden B. The best and worst treatments for Helicobacter pylori. BMJ 2015;351:h4146. [Ref.ID 99411]
23. Cita con resumen
Anónimo. Ceftobiprole médocaril. Prescrire 2015;35:331-5. [Ref.ID 99133]
24. Cita con resumen
Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN, Canadian Drug Safety and Effectiveness Research Network.. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone. Can Med Assoc J 2015;187:E138-143. [Ref.ID 98851]
25. Cita con resumen
Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN, for the Canadian Drug Safety and Effectiveness Research Network. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone. Can Med Assoc J 2015;187:E138-43. [Ref.ID 98766]
26. Cita con resumen
Anónimo. Lésions de la muqueuse oesophagienne d'origine médicamenteuse. Prescrire 2014;34:905-10. [Ref.ID 98473]
27.Tiene citas relacionadas Cita con resumen
Hay D, Hill M, Littlewood T. Neutropenia in primary care. BMJ 2014;349:g5340. [Ref.ID 98347]
28. Cita con resumen
Anónimo. Antibiothérapie des appendicites aigües chez les adultes. Prescrire 2014;34:203-5. [Ref.ID 97366]
29.
Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L, Carp A, Radonjic V, Maqsudova N, Celik HD, Payerl-Pal M, Bak Pedersen H, Sautenkova N, Goossens H, on behalf of the WHO/Europe-ESAC project group. Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. The Lancet Infectious Diseases 2014;14:381-7. [Ref.ID 97304]
30. Cita con resumen
Rao GA, Mann JR, Shoaibi A, Lee Bennett C, Nahhas G, Sutton SS, Jacob S, Strayer SM. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med 2014;12:121-7. [Ref.ID 97224]
31. Cita con resumen
Cherian P, Gunsson T, Borchard K, Tai Y, Smith H, Vinciullo C. Oral antibiotics versus topical decolonization to prevent surgical site infection after Mohs micrographic surgery - a randomized, controlled trial. Dermatologic surgery 2013;39:1486. [Ref.ID 96705]
33. Cita con resumen
Llor C, Moragas A, Bayona C, Morros R, Pera H, Plana-Ripoll O, Cots JM, Miravitlles M. Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial. BMJ 2013;347:12. [Ref.ID 96474]
36.Tiene citas relacionadas Cita con resumen
McMurray JJV, Jhund PS. Cardiovascular risks with azithromycin. N Engl J Med 2013;369:579. [Ref.ID 95973]
39. Cita con resumen
Anónimo. Bismuth + métronidazole + tétracycline. Prescrire 2013;33:92-6. [Ref.ID 94872]
40.Tiene citas relacionadas Cita con resumen
Liou J-M, Chen C-C, Chen M-J, Chen C-C, Chang CY, Fang Y-J, Lee J-Y, Hsu S-J, Luo J-C, Chang W-H, Hsu Y-C, Tseng CH, Tseng PH, Wang H-P, Yang U-C, Shun CT, Lin J-T, Lee Y-C, Wu M-S, for the Taiwan Helicobacter Consortium. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet 2013;381:205-13. [Ref.ID 94796]
Seleccionar todas
 
<< anterior 21 a 40 de 347 siguiente >>